Ergothioneine (EGT) for Rats: Could It Be Their “Taurine”?

By Brian · 17 min read · Last saved September 15, 2026

If you’ve played our science adventure Inner Space: The Sulfur Sentinel, you’ve already steered ergothioneine through a rat’s body and met its limits. This is the real science behind that game, what ergothioneine is, what the published evidence shows (and doesn’t), and why it might matter more for a pet rat than almost anyone realizes. Written straight: some of this is solid, some is a promising hypothesis, and we’ll tell you which is which.

The honest bottom line, up front:

• EGT is a diet-only, exceptionally stable antioxidant the body works hard to hold onto — a sign it matters.
• In animals it’s the real thing: it extends lifespan in mice (and worms) and improves muscle, endurance, and kidney health in aged rats.
• In people, high EGT levels track with longer, healthier lives, but that’s a correlation, and no human trial has proven it extends lifespan.
• It’s remarkably safe, with one of the widest safety margins of any supplement.
• Captive rats almost certainly get very little of it — which raises a real question we take seriously below.
• It is a support, not a cure, and never a substitute for a vet.

What is ergothioneine?

EGT (also written ERGO or ET) is a sulfur-containing amino acid built from histidine. Two things make it unusual:

1. No animal can make it. Not rats, not humans, not your dog. It’s produced only by certain fungi (mushrooms) and soil bacteria, and animals get every bit of it from diet, mushrooms supply the overwhelming majority of dietary EGT.
2. It’s exceptionally stable. Most antioxidants get “used up” and can even turn into mild pro-oxidants after neutralizing a radical. EGT sits in a chemical form (the thione) that lets it mop up the body’s most dangerous radical, the hydroxyl radical, without becoming a problem itself. Unlike glutathione, it doesn’t autoxidize and won’t drive the iron-fueled Fenton reaction; in fact it locks up loose iron and copper to stop it. It’s a guardian that doesn’t turn on you, exactly why the game casts it as a bodyguard.

Because no animal makes it, the body treats EGT as precious. It has a single dedicated doorway, a transporter called OCTN1 (gene SLC22A4), that pulls EGT into cells and concentrates it to levels far above the blood (millimolar inside some tissues), then holds onto it: low urinary loss, avid retention. Rats have a working version of this same transporter, which is part of why rat data apply to your animals.

Could ergothioneine be the “taurine” of rats?

Here’s the idea that makes EGT worth real attention.

In the 1970s–80s, pet cats were going blind and dying of a heart disease, dilated cardiomyopathy (DCM), and it took years to find the cause: a simple dietary deficiency. Cats can’t make enough taurine, the commercial food of the day didn’t supply enough, and the shortfall was quietly wrecking their retinas^[1] and hearts. The heart paper opened with the scale of it: “Thousands of pet cats die each year with dilated cardiomyopathy, the cause of which is unknown.”^[2] Once taurine was added back, early cases could be reversed, and a 2021 veterinary cardiology review can now say that DCM “is rare in cats” and that when it does occur it “is seldom due to taurine deficiency.”^[3] One missing dietary nutrient had been hiding in plain sight for decades.

EGT has the same setup:

• No animal makes it, purely dietary, from mushrooms and soil microbes.
• In people it’s already flagged as a “longevity vitamin” that modern, processed diets fall short on (a term from biochemist Bruce Ames; argued in depth by Penn State’s Robert Beelman), lower intake tracks with worse aging.
• The body fights to keep it, the kidney reabsorbs it rather than lose it, cells hoard it, and stressed tissue builds extra OCTN1 doorways to pull in more. Bodies don’t do that for things they don’t need.
• A captive rat’s diet, lab blocks and kibble, contains essentially no mushrooms. So it’s entirely reasonable to suspect pet rats run chronically low on EGT, perhaps more so than people do.

To be clear, this is a hypothesis, not an established fact. No one has yet measured EGT status across pet rats and shown that supplementing it extends their lives. But the parallel to the taurine story is close enough to take seriously, and it’s a big part of why this molecule, and the game built around it, exist.

A testable hypothesis: are blonde (Rab38) rats especially short on EGT?

This part is speculation built on published facts, we raise it precisely because we want researchers and breeders to test it, not because it’s settled. Three pieces are already in the peer-reviewed literature:

1. The blonde/dilute coat traces to Rab38. The rat “Ruby” coat-dilution locus is the gene Rab38 (Mammalian Genome, 2004).^[4] Rab38 is a small GTPase whose day job is trafficking membrane proteins to their destinations, it routes cargo to specialized “lysosome-related organelles” such as the melanosome, which is why losing it lightens coat color in the first place.^[5]
2. Rab38 also governs the kidney’s proximal tubule, the exact place EGT works. In a rat model, knocking out Rab38 causes protein in the urine, and the mechanism is impaired re-uptake (endocytosis) in the proximal tubule, not a leaky filter (J. Am. Soc. Nephrol., 2013).^[6] The fawn-hooded rat, a natural Rab38 mutant, is a long-standing model of progressive kidney disease.
3. EGT’s transporter, OCTN1, lives and works in that same proximal tubule, where the kidney reabsorbs EGT rather than lose it.

Now the inference, which to our knowledge no one has tested: if Rab38 traffics membrane transporters in the proximal tubule, is OCTN1 one of the proteins it delivers to the cell surface? If it is, a Rab38-deficient (blonde/dilute) rat might fail to put enough OCTN1 where it belongs, and would then absorb and retain less EGT, ending up especially deficient and especially dependent on getting EGT from the diet. It would also tie together two things already documented in Rab38-mutant rats: lighter coats and vulnerable kidneys.

That’s a hypothesis, not a finding, and the bridge step (OCTN1 as Rab38 cargo) is unproven. But it would be straightforward for a lab to test: compare OCTN1 surface localization and tissue EGT levels in Rab38-normal vs. Rab38-deficient rats, and see whether dietary EGT changes the kidney outcome. If you’re a researcher or a serious breeder, please run it, we would rather put the question out there and have it proven or disproven than sit on it. Either way it sharpens the practical point: keeping EGT in the diet is low-risk and plausibly high-value, and possibly most of all for the blonde rats this colony is named for.

Why a rat keeper might care

Rats are short-lived and especially prone to two age-related failures EGT happens to touch:

• Kidneys. Age-related chronic kidney decline is one of the most common ways pet rats fail. EGT concentrates heavily in the kidney’s proximal tubule, the part that does the filtering, and in rodents it protects that tissue and slows the slide from acute injury to chronic disease. There’s a striking twist the game uses: chronic kidney disease itself lowers the body’s EGT (by disrupting the gut transporter that absorbs it), while a stressed kidney builds more OCTN1 doorways to call EGT in. The kidney “asks” for the hero, and disease starves it of exactly that help.
• Muscle, energy, and lifespan (the 2024–25 headlines). In male mice, a low daily dose (~4–5 mg/kg in drinking water) started young and continued for life raised median lifespan ~16% and pushed back late-life mortality ~29%, with less age-related decline and more new brain-cell growth.^[7] In aged rats, EGT roughly doubled treadmill endurance and increased muscle mass and blood-vessel density (Cell Metabolism, 2025).^[8] The mechanism is genuinely new: EGT isn’t an NAD⁺ “raw material” like NMN or NR, it’s a trigger. It feeds an enzyme (CSE) that releases a small burst of hydrogen-sulfide signal, which tags hundreds of proteins and switches on the machinery that regenerates NAD⁺, the cell’s core energy currency that fades with age.^[8]

On top of that, EGT crosses into the brain, calms inflammatory signaling, and, in large human population studies, higher blood levels track with less heart disease and lower mortality (about 3,200 people followed for 21 years).^[9] That last point is the exciting one and the one to be most careful about: it’s a correlation. EGT was, in fact, the metabolite most tied to a health-conscious diet, so the people with high EGT also did a hundred other healthy things.

How EGT actually works — and its four real conditions (the science behind the game)

The game isn’t “spam the power-up” because EGT only works under real conditions. Two are hard limits; two are ordinary caveats people tend to overstate. Here’s the honest version of each:

1. The gate (OCTN1), a real limit. EGT can’t enter a cell that lacks the OCTN1 transporter. No doorway, no effect. That’s why EGT acts in specific tissues (kidney, marrow, liver, gut, brain, oxidative muscle) rather than everywhere at once.
2. The activator (CSE), a real limit. EGT’s headline NAD⁺/longevity effect only fires in cells with a working CSE enzyme; remove CSE in the lab and that benefit disappears entirely. In aged or damaged cells, the very machinery EGT needs can be the thing that’s failing.
3. The “more isn’t better” curve (H₂S), the usual caveat, with an unusually wide window. The H₂S signal EGT triggers helps in a small pulse; in theory a flood of sulfide could harm. But this is just the U-shaped dose-response nearly every nutrient has, folate, selenium, vitamin A, iron, even water. What sets EGT apart is how wide its safe window is: the no-harm dose in rats (800 mg/kg/day) is hundreds of times the doses that help,^[10] and there’s no evidence real-world EGT use gets anywhere near trouble. Ordinary “don’t megadose,” not a special danger.
4. The cancer question, genuinely two-sided. Tumors lean on antioxidant defences, and OCTN1 is the doorway EGT uses,^[11] so there is a theoretical worry that loading up on EGT could help an existing cancer defend itself. That worry is an argument from general antioxidant biology rather than a measurement: we looked for a study of OCTN1 or EGT inside a rat tumor and did not find one. It cuts the other way too, and that half is measured: preventing oxidative damage prevents DNA mutations that start cancers, and EGT has been shown to kill colorectal-cancer cells outright by triggering a form of programmed cell death.^[12] The science is split. The sensible posture is balance, and a vet’s input if a rat actually has a tumor, not avoidance.

So is it proven?

• Solid: the chemistry (a stable, non-self-oxidizing radical scavenger and metal chelator); the diet-only origin and the OCTN1 gate, confirmed in rats; the CSE→H₂S→NAD⁺ cascade; lifespan extension in mice and worms; muscle/endurance gains and kidney protection in rodents; the wide safety margin.
• Promising but unproven for your rats: that captive pet rats are EGT-deficient, and that supplementing it lengthens their lives specifically. The strongest mammalian lifespan data are in mice; the rat work is shorter-term healthspan; the human longevity data are correlation only. We’d rather say that plainly than oversell it.

Dose, sources, and safety

• Where it comes from: mushrooms are by far the richest food source (oyster and king-oyster especially), with smaller amounts in some beans, organ meats, and grains. A formulated lab block plus the occasional mushroom keeps EGT in the diet, though it won’t reach research doses. Purified L-ergothioneine supplements also exist.
• What doses appear in the research (clearly labeled, not a prescription): the mouse lifespan benefit appeared at a low ~4 to 5 mg/kg/day;^[7] the aged-rat functional work used higher doses than the mouse lifespan study;^[8] older renal-protection work used up to ~70 mg/kg/day.^[13] Working back from the ergothioneine content of ordinary mushrooms, a conservative dietary equivalent is roughly 1 to 3 mg/kg/day, which is this site’s own arithmetic rather than a published figure. Every one of these sits far below any dose where harm appears.
• Safety: L-ergothioneine is approved as a novel food in the EU and is the subject of US FDA GRAS notices.^[14] The no-adverse-effect level in rats is 800 mg/kg/day, with safety margins of 216 to 470 and no genotoxicity found.^[10] A one-generation rat reproduction study found no effect on fertility and no maternal or developmental toxicity.^[15] As supplements go, the margin is enormous.
• What this colony actually does, measured by the spoon: Brian’s instruction for the water bottle is ⅛ teaspoon of ergothioneine per US gallon. The spoon is the specification and the milligrams are a derived convenience: at the bulk density listed for a 99.99% L-ergothioneine powder that comes to roughly 105 mg/L,^[16] which at the 100 mL per kg per day a rat drinks works out to roughly 10 mg/kg/day. The conversion is approximate because powders vary in how densely they pack, which is why we give the spoon rather than the milligram. Our free dosing calculator does the arithmetic for you.

Why this belongs in rat food

Come back to the cats. Taurine deficiency wasn’t fixed by owners dosing their cats one by one, it was fixed by the food industry.^[17][3] After the 1987 discovery, cat food was reformulated and the standard-setting body (AAFCO) wrote taurine minimums into its cat-food nutrient profiles. That last step lives in AAFCO’s own publication, which we could not reach to link, so take it as told rather than as shown. The before and the after are both shown, higher up this page: thousands of pet cats a year when the cause was found,^[2] rare today and seldom a taurine disease when it does appear.^[3] The fix was systemic and permanent.

Nothing like that has happened for EGT in rat food, because it isn’t on anyone’s radar. Commercial rodent diets are built around protein, fat, fiber, vitamins, and minerals; ergothioneine isn’t a line item anyone is thinking about, even though it’s diet-only, even though the body guards it like something essential, even though it concentrates in the organs that most often fail aging rats, and even though it’s cheap, safe, and shelf-stable. A lab block fortified with a few mg/kg of EGT, in the range that extended lifespan in mice, would cost very little and might do real good.

We think that’s worth changing:

• If you make or formulate rodent diets: put EGT on the list to evaluate. The safety case is already strong (EU novel food; rat NOAEL 800 mg/kg/day).^[10]
• If you’re a researcher: the pet-rat deficiency question and the Rab38/OCTN1 question above are both wide open and cheap to test.
• If you keep rats: you don’t have to wait, you can add it to the diet yourself today.

The taurine story shows how fast this can move once people start paying attention. Getting EGT onto that radar is a big part of why this page exists.

The bottom line

Ergothioneine is a borrowed guardian: a remarkably safe,^[10] genuinely interesting molecule your rats can only get from food,^[18] that only one dedicated transporter can carry into a cell, so it builds up in some tissues and not others,^[19] highest in the kidney and liver of a mouse and lowest in its skeletal muscle,^[20] that extends lifespan in mice,^[7] and that captive rats probably don’t get nearly enough of. Whether it turns out to be the “taurine moment” for rats is still an open question, but it’s a question worth asking, and a reasonable thing to keep in the diet while the science fills in.

It is not a cure, not an antibiotic, and not a reason to skip a vet. A rat with labored breathing, weight loss, or any sudden change needs veterinary care. No supplement replaces that.

Next: Play Inner Space: The Sulfur Sentinel · Open the dosing calculator (EGT) · Rat diet, food & treats

---

Sources & further reading

All facts above were verified against the primary literature (June 2026). Selected sources:

• Katsube et al. 2024, GeroScience 46:3889–3909, ergothioneine extends lifespan in male mice (~4–5 mg/kg/day; +16% median lifespan).
• Petrovic et al. 2025, Cell Metabolism, EGT improves healthspan in aged rats via the CSE→H₂S→cGPDH→NAD⁺ cascade (PMID 39842434).
• Smith et al. 2020, Heart 106(9):691–697, plasma EGT associated with lower mortality and cardiovascular disease (Malmö Diet & Cancer, n≈3,236).
• Beelman et al. 2020/2022, EGT as a “longevity vitamin” limited in the modern diet (PMID 33244403).
• EFSA 2016, EFSA Journal 14(11):4629, safety of synthetic L-ergothioneine (novel food); rat NOAEL 800 mg/kg/day.
• Kidney International 2017, CKD lowers EGT via intestinal OCTN1 dysfunction; AKI→CKD protection (PMID 40633826).
• Discovery of the EGT transporter OCTN1/SLC22A4: PNAS 2005. Rat Octn1 transports EGT: PMID 18670092.
• Taurine precedent, Pion et al. 1987, Science 237:764–768; manufacturers reformulated and AAFCO set cat-food taurine minimums, after which diet-related feline DCM became rare.
• Rab38 hypothesis scaffolding, rat Ruby locus = Rab38 (Oiso et al. 2004, Mammalian Genome); Rab38 modulates proteinuria via proximal-tubule re-uptake (Rangel-Filho et al. 2013, J. Am. Soc. Nephrol. 24:283–292, PMID 23291471). Whether OCTN1 is Rab38 cargo is, as of June 2026, untested.

References

• [1] Hayes KC, Carey RE, Schmidt SY. “Retinal degeneration associated with taurine deficiency in the cat.” Science 1975;188(4191):949-951. PubMed.
• [2] Pion PD et al. “Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy.” Science 1987;237:764-768. PubMed.
• [3] Kittleson MD, Côté E. “The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.” Journal of Feline Medicine and Surgery 2021;23(11):1053-1067. PubMed.
• [4] Oiso N et al. “The rat Ruby (R) locus is Rab38: identical mutations in Fawn-hooded and Tester-Moriyama rats derived from an ancestral Long Evans rat sub-strain.” Mammalian Genome 2004;15(4):307-314. PubMed.
• [5] Wasmeier C et al. “Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes.” Journal of Cell Biology 2006;175(2):271-281. PubMed.
• [6] Rangel-Filho A et al. “Rab38 modulates proteinuria in model of hypertension-associated renal disease.” Journal of the American Society of Nephrology 2013;24(2):283-292. PubMed.
• [7] Katsube M et al. “Ergothioneine promotes longevity and healthy aging in male mice.” GeroScience 2024;46:3889-3909. PubMed.
• [8] Petrovic D et al. “Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidation.” Cell Metabolism 2025;37(2):542-556.e14. PubMed.
• [9] Smith E et al. “Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease.” Heart 2020;106(9):691-697. PubMed.
• [10] EFSA NDA Panel. “Safety of synthetic l-ergothioneine (Ergoneine) as a novel food pursuant to Regulation (EC) No 258/97.” EFSA Journal 2016;14(11):4629. DOI.
• [11] Yi G, Yao D, Dong C, Tu X, Liao G, Long M, Xie Y. “Ergothioneine: Biosynthesis, Molecular Mechanisms, Physiological Function, and Role in Disease.” MedComm 2026;7(9):e70947. PubMed.
• [12] D’Onofrio N, Martino E, Balestrieri A, et al. “Diet-derived ergothioneine induces necroptosis in colorectal cancer cells by activating the SIRT3/MLKL pathway.” FEBS Letters 2022;596(10):1313-1329. PubMed.
• [13] Salama SA, Abd-Allah GM, Mohamadin AM. “Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-kB, and apoptotic signaling and inhibiting gamma-glutamyl transpeptidase.” Life Sciences 2021;278:119572. PubMed.
• [14] US Food and Drug Administration. “GRAS Notice Inventory: search results for ergothioneine.” link.
• [15] Forster R, Spézia F, Papineau D, et al. “Reproductive safety evaluation of L-Ergothioneine.” Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2015;80:85-91. PubMed.
• [16] ProVita Biotech. “Bulk L-Ergothioneine Powder, certificate of analysis.” link.
• [17] Pion PD. “Traditional and nontraditional effective and noneffective therapies for cardiac disease in dogs and cats.” Veterinary Clinics of North America: Small Animal Practice 2004;34(1):187-216. PubMed.
• [18] Cheah IK, Halliwell B. “Ergothioneine; antioxidant potential, physiological function and role in disease.” Biochimica et Biophysica Acta 2012;1822(5):784-793. PubMed.
• [19] Gründemann D, Hartmann L, Flögel S. “The ergothioneine transporter (ETT): substrates and locations, an inventory.” FEBS Letters 2022;596(10):1252-1269. PubMed.
• [20] Nagana Gowda GA, Zhu W, Pascua V, McMillen T, Tian R, Raftery D. “Identification and Distribution of the Dietary Antioxidant Ergothioneine in Humans and Animal Models Combining NMR, RANSY, and MS Methods.” Analytical Chemistry 2025;97(35):19313-19320. PubMed.